$RSCF

REFLECT SCIENTIFIC, INC.

1
1
0

No SEC Form 4 filings for $RSCF in the last 30 days.

See all $RSCF insider activity →
Low

Reflect Scientific launches dual-mode ultra-low freezer

Reflect Scientific Inc. (RSCF) launched the PF-90 Blast Plate Freezer, a dual-mode ultra-low freezer for biopharmaceuticals and vaccines. The device operates between -40°C and -90°C, with a 20-year warranty. The company cites a growing market for blast freezers, estimated at $1.84B in 2025, and a biomedical refrigerator and freezer market at $4.34B in 2025.

RSCF sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 2 news stories mentioning RSCF (REFLECT SCIENTIFIC, INC.). Coverage has skewed bullish: 1 bullish, 1 neutral, and 0 bearish.

What's driving RSCF

  • New product launch may modestly boost sales outlook but limited immediate impact.

    investing.com · Oct 13, 2026

  • The announcement of over $250,000 in new orders from international biotech and pharma clients suggests increased demand for Reflect Scientific's products, potentially signaling a positive outlook for the company's stock.

    Benzinga · May 20, 2025

  • Reflect Scientific's patented cryogenic solutions position it favorably within the growing AI data center cooling market, potentially leading to increased revenue and market share.

    Benzinga · May 19, 2025

AlphAI scores every news story that mentions RSCF with an AI model for sentiment and relevance, and aggregates insider trades from REFLECT SCIENTIFIC, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $RSCF

Score
$RSCFLow

Reflect Scientific launches dual-mode ultra-low freezer

Reflect Scientific Inc. (RSCF) launched the PF-90 Blast Plate Freezer, a dual-mode ultra-low freezer for biopharmaceuticals and vaccines. The device operates between -40°C and -90°C, with a 20-year warranty. The company cites a growing market for blast freezers, estimated at $1.84B in 2025, and a biomedical refrigerator and freezer market at $4.34B in 2025.

Related tickers